Growing evidence indicates that serine proteases known as kallikreins are associated with malignancy and may have potential diagnostic/prognostic applications in cancer. Kallikreins are the largest group of serine proteases. Kallikrein enzymes are often involved in proteolytic cascades through their function in degradation of extracellular matrix proteins and promotion of angiogenesis. Kallikrein 6 (KLK6) is a member of the family of fifteen highly conserved secreted trypsin- or chemotrypsin-like serine proteases. Over-expression of KLK6 has been observed in different pathophysiological states such as neurodegenerative diseases, inflammation and various cancers, including colorectal cancer. In Chapter 3 we elucidated the miRNA-based mechanism of regulation of invasion in metastatic colorectal cancer over-expressing KLK6. We developed HCT116 colon stable isogenic cell lines with knockdown of KLK6 expression using short-hairpin interference RNA (shKLK6 clones). The shKLK6 clones had decreased expression and secretion of KLK6 protein with a minimal effect on cell growth and viability in cell culture. SCID mice injected with shKLK6-3 clone 3 cells exhibited a statistically significant increase in the survival rates (P=0.005), decrease in the incidence of distant metastases and a shift in the location of the metastatic foci closer to the cell's injection site. Levels of KLK6 protein secreted into the bloodstream were significantly lower in animals injected with shKLK6-3 clone 3 compared to HCT116 control clone 1 (P < 0.04). Through bioinformatics analyses we identified and validated three miRNAs, which are important in post-translational modification of bioactive proteins, proliferation, migration and p38 MAPK signaling pathway. In Chapter 4 we developed Caco-2 colon stable isogenic cell lines with expressing enzymatically active or mutant KLK6 protein (Caco-2 stable clones). We employed these cell lines to investigate the importance of KLK6 enzymatic activity of initiation of cell invasion using in vitro and in vivo models.

Blood fluke Schistosoma mansoni is one of the most important human parasites. Proteolytic system of schistosoma is crucial for parasite - host interactions. Therefore some of the proteases became potential therapeutic targets. This work is focused on not yet characterized serine protease SmSP2. SmSP2 is newly discovered protease of S. mansoni, whose biological role is unknown. This protease is highly expressed in developmental stages parasitizing humans. SmSP2 was recombinantly expressed in prokaryotic and eukaryotic expression system (E. coli a P. pastoris) and purified using chromatographic methods. Recombinant SmSP2 was used for polyclonal antibody production. Conditions for refolding were optimized. Basic biochemical properties of the protease were detected and substrate amino acid preferences for P1 - P4 sites for single aminoacids were identified using synthetic fluorogenic peptides for positional scanning substrate combinatorial library (PS-SCL). (In Czech)

Trichobilharzia spp. are avian schistosomes related to medically important human parasites of the genus Schistosoma. Penetrating cercariae are well known as causative agent of cercarial dermatitis in humans. Cercariae actively penetrate the skin of definitive hosts and transform into schistosomula. This process is preceded by cercarial tail detachment and includes emptying of penetration glands and extensive surface changes. One of these changes is the loss of highly immunogenic glycocalyx which represents a protective coat in the aquatic environment. The glycocalyx has specific composition of saccharide molecules which are bound to lipids or proteins on the membrane of cercarial tegument. There is only limited information about the mechanism of shedding. Hypotheses based on indirect evidences suggest that peptidases or (phospho)lipases from penetration glands could be involved. This work describes the changes in surface glycosylation during transformation of cercariae into schistosomula by fluorescently labelled lectins and monoclonal antibodies against Lewis X antigen. Lectins UEA-I, LTA and PNA have been chosen as markers of transformation of T. regenti. Further, our experiments have been focused on shedding of cercarial glycocalyx. During in vitro induction of penetration gland emptying and...

Dentre as substâncias químicas secretadas pelas plantas, contra os insetos herbívoros, os inibidores de peptidases são de grande interesse. A atenção dada a esses inibidores deve-se ao fato, de eles serem uma boa alternativa no controle de insetos praga, uma vez que não causam danos ao meio ambiente. Contudo, muitas espécies de insetos são capazes de escapar dos efeitos negativos dos inibidores de peptidases das plantas, via diferentes mecanismos adaptativos. Devido a esse fato, é importante compreender os mecanismos desenvolvidos pelos insetos para burlar os efeitos dos inibidores de peptidases das plantas. Diante desse panorama, este trabalho teve como objetivo estudar o mecanismo adaptativo das serina endopeptidases de Spodoptera frugiperda aos inibidores de endopeptidases de soja. Foram realizadas análises do transcriptoma dos intestinos das lagartas mantidas em exposição crônica ao inibidor. Para averiguar os efeitos causados devido à exposição crônica ao inibidor, foram realizadas comparações da expressão relativa, dos genes de tripsinas e quimotripsinas, de intestinos de lagartas de sexto instar. Contudo, para entender o efeito da exposição aguda ao inibidor, lagartas de S. frugiperda foram criadas em dieta artificial controle até o primeiro dia do sexto instar, após esse período elas foram transferidas para dieta artificial acrescida com 0,5 % dos inibidores de endopeptidases de soja, durante 48 horas. Para verificar a ocorrência de um possível controle epigenético na expressão dos genes, as lagartas foram conduzidas até a fase adulta e os adultos, de cada tratamento, foram acasalados entre si, constituindo uma segunda geração. Dados de expressão relativa foram obtidos, de indivíduos da primeira e segunda geração, e foram então comparados. Foram identificados 14 possíveis genes de quimotripsinas e nove possíveis genes de tripsinas. Os genes de tripsina foram divididos em dois grupos distintos em relação a sua sensibilidade aos inibidores de endopepetidases de soja e expressão relativa. Houve uma resposta diferenciada na ativação dos genes de serina endopeptidases de S. frugiperda, a qual dividiu os genes em dois grupos, os responsivos e os não responsivos ao inibidor. A exposição aguda ao inibidor ativou um pequeno grupo de genes, enquanto que a exposição crônica promoveu uma maior amplitude de expressão gênica, sugerindo mecanismos temporalmente regulados. Por último, evidências indicam, pela primeira vez, a possível ocorrência de um mecanismo epigenético, na resposta das enzimas digestivas aos inibidores de serina endopeptidases de soja. / Among the chemicals secreted by plants against insect herbivores, peptidase inhibitors (PIs) are of great interest. The attention given to PIs is due to the fact that they are a good alternative to control insect pests since they do not cause damage to human health and the environment. However, many species of insects are able to escape the negative effects of PIs plants via different adaptive mechanisms. Because of this, it is important to understand the mechanisms developed by insects to circumvent the effects of PIs plants. Against this background, this research aimed to study the adaptive mechanism of serine endopeptidases Spodoptera frugiperda to soybean endopeptidase inhibitors. For this purpose, larvae of S. frugiperda were reared on artificial diet and control artificial diet plus 0.5% of endopeptidase inhibitors of soybean. We conducted a transcriptome midgut of worms maintained in chronic ingestion of the inhibitor. The relative expression of the genes, trypsin and chymotrypsin, was also compared the midgut of sixth instar larvae kept in these diets. In another experiment, the larvae were conducted to moth, then the treatments were mated forming a second generation. Relative expression data were obtained for individuals of the first and second generation, and then compared. Identified 14 genes with potential of chymotrypsin and 9 trypsin like genes. The trypsin gene were divided into two groups for both their sensitivity to PI soybean endopeptidase, and for their relative expression pattern. There was a differentiated response on the genes activation of S. frugiperda serina endopeptidases. The genes were clustered in 2 groups, the responsive ones and the non responsive to the inhibitor. The acute exposition to the inhibitor activated a small group of genes and the chronic exposition affected several genes, indicating the existence of temporal regulated mechanism. Besides, there is a possible occurance of an epigenetic mechanism, which is related to the digestive serina endopeptidases inhibitors of soybean.

The membrane proteins signal peptide peptidase, signal peptide peptidase like and presenilin are intramembrane aspartyl proteases located in the endoplasmic reticulum, plasma membrane and organelle. These membrane proteins are able to catalyze a hydrolytic reaction in a hydrophobic space. The downstream consequences of these reactions impact a variety of cellular functions such as cytokine production, inflammatory responses, embryogenesis, and immune system regulation. Additionally, the aspartyl proteases such as signal peptide peptidase and presenilin, a part of the γ-secretase complex, hydrolyze peptides leading to pathogen maturation and Alzheimer’s disease, respectively. Electron crystallography offers the unique aspect of studying membrane proteins in a near native state. Determining the structures of Haloarcula morismortui and Methanoculleus marisnigri JR1 signal peptide peptidases by electron crystallography may provide insight into how a hydrolysis reaction occurs in a hydrophobic environment and how the protein determines which transmembrane signal peptides to cleave. Additionally, structure determination may help answer questions regarding why human presenilin, part of the γ-secretase complex, incorrectly processes amyloid precursor protein into amyloid-beta peptides leading to Alzheimer’s disease. Such structural data may not only shed light on how amyloid precursor protein is processed but how other proteins are processed by signal peptide peptidase leading to immune responses, cell signaling, and pathogen maturation. In addition, structure-function data may have an impact on pharmaceutical drug designs that targets signal peptide peptidase, signal peptide peptidase like, and/or presenilin. To determine the structure of aspartyl proteases, two archaeal signal peptide peptidases were used for two-dimensional crystallization trials to be able to study their structure by electron crystallography. Haloarcula morismortui and Methanoculleus marisnigri JR1 signal peptide peptidases, both human signal peptide peptidase homologues, were recombinantly over-expressed and purified. During dialysis trials, various lipid-to-protein ratios, sodium chloride concentrations, temperatures, detergents and a variety of other variables were tested. Methanoculleus marisnigri JR1 signal peptide peptidase showed the most promising results in terms of crystallinity. Optimizing dialysis conditions, specifically narrowing the lipid to protein ratio, resulted in two-dimensional crystals. Ordered arrays measuring up to 200 nm x 200 nm were observed. These ordered arrays have been shown to be reproducible amongst multiple batches of purified Methanoculleus marisnigri JR1 signal peptide peptidase. Preliminary projection maps of negatively stained ordered arrays show unit cell dimensions of a = 178 Å, b = 160 Å, γ = 92.0 Å and a = 175 Å, b = 167 Å, γ = 92.0 Å. The monomer measurements are approximately 70 Å by 80 Å. This is the first time a signal peptide peptidase homologue has been crystallized by two-dimensional crystallization.

O câncer cervical é uma das neoplasias mais prevalentes, sendo a segunda mais frequente em mulheres no Brasil. A exoprotease dipeptidil-peptidase IV (DPPIV), também conhecida como CD26, é uma enzima encontrada em uma diversidade de células, e sua atividade enzimática e interação com outras proteínas parecem ser fundamentais para o controle da transformação maligna e progressão tumoral. Esta enzima é encontrada ancorada na membrana celular e também como uma isoforma solúvel (DPPIV/sCD26), ativa em fluidos biológicos. Pesquisas demonstram que alterações em sua expressão e atividade têm sido observadas em diversos tumores. Tendo em vista a relação entre a DPPIV/CD26 e o câncer, neste estudo investigamos a atividade e expressão da DPPIV/CD26 em linhagens celulares de câncer cervical (SiHa, HeLa and C33A) e de queratinócitos imortalizados (HaCaT). A atividade enzimática também foi monitorada na presença do inibidor específico da DPPIV/CD26, o fosfato de sitagliptina. Avaliamos também a relação desta enzima com os mecanismos de migração e adesão celular. Nossos resultados demonstram que todas as linhagens estudadas apresentam atividade enzimática DPPIV/CD26 ligada à membrana e solúvel, sendo superior nas linhagens SiHa e HaCaT. Confirmamos que esta atividade é atribuída à DPPIV/CD26 pela inibição da sua atividade enzimática na presença de fosfato de sitagliptina. Uma maior expressão do gene da DPPIV/CD26 foi observada nas linhagens HaCaT e SiHa, uma baixa expressão na C33A, sendo praticamente indetectável na HeLa. Estes dados corroboram os resultados obtidos para a atividade enzimática. Foi observada uma maior capacidade migratória na linhagem HeLa, quando comparada a SiHa, porém na presença de fosfato de sitagliptina, a linhagem SiHa apresentou um aumento na migração. Além disso, na presença do inibidor, tanto a linhagem HeLa quanto a SiHa exibiram uma redução na adesão celular. Este estudo demonstra a presença da enzima DPPIV/CD26 em células de câncer cervical, revelando diferentes níveis de expressão, e sua relação com a migração e adesão celular. / Cervical cancer is one of the most prevalent neoplasias, being the second most frequent in women in Brazil. The exoprotease dipeptidyl peptidase IV (DPPIV), also known as CD26, is an enzyme found in a variety of cells, and its enzymatic activity and interaction with other proteins appear to be essential for the control of malignant transformation and tumor progression. This enzyme is found anchored to the cell membrane and also as a soluble isoform (DPPIV/sCD26), active in biological fluids. Studies have shown changes in their expression and activity in several tumor types. Given the relationship between DPPIV/CD26 and cancer, in the present study, we investigated DPPIV/CD26 activity and expression in cervical cancer cell lines (SiHa, HeLa and C33A) and immortalized keratinocytes (HaCaT). Enzymatic activity was also monitored in the presence of the specific DPPIV/CD26 inhibitor, sitagliptin phosphate. We also evaluated the relationship of this enzyme with cell migration and adhesion. Our results show that all cell lines studied exhibit DPPIV/CD26 enzymatic activity both membrane-bound and in soluble form, being higher in SiHa and HaCaT. We confirm that this activity is attributed to DPPIV/CD26 by its inhibition in the presence of sitagliptin phosphate. We observed a higher expression of DPPIV/CD26 in HaCaT and SiHa cell lines, a low expression in C33A and in HeLa cells this expression was almost undetectable. These data corroborate the results obtained for enzymatic activity. We observed a higher migratory capacity of HeLa, when compared to SiHa, but in the presence of sitagliptin phosphate, SiHa showed an increase in migration. Furthermore, in the presence of the inhibitor, SiHa and HeLa cells exhibited a reduction in cell adhesion. This study demonstrates the presence of DPPIV/CD26 in cervical cancer cells, revealing a differential expression and its relationship with cell migration and adhesion.

Made available in DSpace on 2016-06-02T20:21:36Z (GMT). No. of bitstreams: 1 6407.pdf: 1899401 bytes, checksum: d7929c149990e2a77bfc5e204bc566f5 (MD5) Previous issue date: 2014-09-04 / Universidade Federal de Minas Gerais / Cysteine proteases (CPs) are proteolytic enzymes which have a cysteine residue at its active site. Plant legumains are CPs known as vacuolar processing enzymes and they play key roles in seed maturation, germination, senescence, stress response, programmed cell death during development and defense against pathogens. Although there are many studies about plant legumains, most of them is related to legumain functions in seeds of dicotyledonous. To date, only one legumain from sugarcane has been described. In this study, it was performed the characterization of a new sugarcane legumain, named CaneLEG2. The recombinant CaneLEG2 was produced in the heterologous expression system Pichia pastoris and its kinetic characterization showed that it exhibits self-activation and activity under acidic pH, which are common features of plant legumains. This study also demonstrated that the sugarcane cystatin CaneCPI-3 has a strong inhibition over the CaneLEG2 activity, suggesting that this cystatin may participate of the regulation of endogenous cysteine proteases. The results obtained in this work will support the understanding of the functions of CaneLEG2 and CaneCPI-3 in sugarcane. / As cisteino-peptidases (CPs) são enzimas proteoliticas que possuem um resíduo de cisteina em seu sitio ativo. As legumainas de plantas são CPs conhecidas como enzimas de processamento vacuolar (VPE) e participam nos processos de maturação de sementes, germinação, senescência, resposta a estresses, morte celular programada no desenvolvimento da planta ou em resposta ao ataque de patógenos. Embora existam diversos estudos com legumainas de plantas, a maioria deles esta relacionada as funções das legumainas em sementes de dicotiledoneas. Ate o momento, apenas uma legumaina de cana-de-açúcar havia sido descrita. Neste presente trabalho, foi realizada a caracterização de uma nova legumaina de cana-de-açúcar, denominada CaneLEG2. A CaneLEG2 recombinante foi produzida em sistema de expressão heterologa Pichia pastoris e sua caracterização cinetica mostrou que ela apresenta auto-ativação e atividade em pH ácido, caracteristicas comuns em legumainas de plantas. Esse estudo ainda demonstrou que a cistatina de cana-de-açúcar CaneCPI-3 exerce uma forte inibição sobre a atividade da CaneLEG2, sugerindo que essa cistatina pode atuar na regulação de cisteino-peptidases endógenas. Os resultados obtidos neste trabalho ajudam no entendimento das funções exercidas pela CaneLEG2 e CaneCPI-3 na cana-de-açúcar.

O câncer cervical é uma das neoplasias mais prevalentes, sendo a segunda mais frequente em mulheres no Brasil. A exoprotease dipeptidil-peptidase IV (DPPIV), também conhecida como CD26, é uma enzima encontrada em uma diversidade de células, e sua atividade enzimática e interação com outras proteínas parecem ser fundamentais para o controle da transformação maligna e progressão tumoral. Esta enzima é encontrada ancorada na membrana celular e também como uma isoforma solúvel (DPPIV/sCD26), ativa em fluidos biológicos. Pesquisas demonstram que alterações em sua expressão e atividade têm sido observadas em diversos tumores. Tendo em vista a relação entre a DPPIV/CD26 e o câncer, neste estudo investigamos a atividade e expressão da DPPIV/CD26 em linhagens celulares de câncer cervical (SiHa, HeLa and C33A) e de queratinócitos imortalizados (HaCaT). A atividade enzimática também foi monitorada na presença do inibidor específico da DPPIV/CD26, o fosfato de sitagliptina. Avaliamos também a relação desta enzima com os mecanismos de migração e adesão celular. Nossos resultados demonstram que todas as linhagens estudadas apresentam atividade enzimática DPPIV/CD26 ligada à membrana e solúvel, sendo superior nas linhagens SiHa e HaCaT. Confirmamos que esta atividade é atribuída à DPPIV/CD26 pela inibição da sua atividade enzimática na presença de fosfato de sitagliptina. Uma maior expressão do gene da DPPIV/CD26 foi observada nas linhagens HaCaT e SiHa, uma baixa expressão na C33A, sendo praticamente indetectável na HeLa. Estes dados corroboram os resultados obtidos para a atividade enzimática. Foi observada uma maior capacidade migratória na linhagem HeLa, quando comparada a SiHa, porém na presença de fosfato de sitagliptina, a linhagem SiHa apresentou um aumento na migração. Além disso, na presença do inibidor, tanto a linhagem HeLa quanto a SiHa exibiram uma redução na adesão celular. Este estudo demonstra a presença da enzima DPPIV/CD26 em células de câncer cervical, revelando diferentes níveis de expressão, e sua relação com a migração e adesão celular. / Cervical cancer is one of the most prevalent neoplasias, being the second most frequent in women in Brazil. The exoprotease dipeptidyl peptidase IV (DPPIV), also known as CD26, is an enzyme found in a variety of cells, and its enzymatic activity and interaction with other proteins appear to be essential for the control of malignant transformation and tumor progression. This enzyme is found anchored to the cell membrane and also as a soluble isoform (DPPIV/sCD26), active in biological fluids. Studies have shown changes in their expression and activity in several tumor types. Given the relationship between DPPIV/CD26 and cancer, in the present study, we investigated DPPIV/CD26 activity and expression in cervical cancer cell lines (SiHa, HeLa and C33A) and immortalized keratinocytes (HaCaT). Enzymatic activity was also monitored in the presence of the specific DPPIV/CD26 inhibitor, sitagliptin phosphate. We also evaluated the relationship of this enzyme with cell migration and adhesion. Our results show that all cell lines studied exhibit DPPIV/CD26 enzymatic activity both membrane-bound and in soluble form, being higher in SiHa and HaCaT. We confirm that this activity is attributed to DPPIV/CD26 by its inhibition in the presence of sitagliptin phosphate. We observed a higher expression of DPPIV/CD26 in HaCaT and SiHa cell lines, a low expression in C33A and in HeLa cells this expression was almost undetectable. These data corroborate the results obtained for enzymatic activity. We observed a higher migratory capacity of HeLa, when compared to SiHa, but in the presence of sitagliptin phosphate, SiHa showed an increase in migration. Furthermore, in the presence of the inhibitor, SiHa and HeLa cells exhibited a reduction in cell adhesion. This study demonstrates the presence of DPPIV/CD26 in cervical cancer cells, revealing a differential expression and its relationship with cell migration and adhesion.

La modification post-traductionnelle des chimiokines par la dipeptidyl peptidase-4 (DPP4 ou CD26) régule négativement le trafic des lymphocytes, et son inhibition améliore la migration des lymphocytes T et l'immunité anti-tumorale en préservant la forme fonctionnelle de CXCL10. En étendant ces résultats initiaux aux humains et à un modèle préclinique de carcinome hépatocellulaire, nous avons découvert un nouveau mécanisme par lequel l'inhibition de DPP4 améliore les réponses anti-tumorales par le recrutement des éosinophiles. Plus précisément, l'administration d'inhibiteurs de DPP4 (DPP4i) conduit à des concentrations tumorales plus élevées de CCL11 (ou eotaxine) et à une augmentation de la migration des éosinophiles exprimant CCR3 dans les tumeurs. Un meilleur contrôle de la croissance tumorale a été observé lors du traitement par DPP4i, un effet conservé chez les souris Rag2–/– mais abrogé uniquement lors de la déplétion des éosinophiles ou de l'inhibition de leur dégranulation. Nous avons également démontré que l'expression tumorale d’IL-33 était nécessaire et suffisante pour une réponse anti-tumorale médiée par les éosinophiles et que ce mécanisme contribuait à l'efficacité des inhibiteurs de points de contrôle immunitaires. Ces résultats révèlent un nouveau mécanisme par lequel le contrôle tumoral est médiée par IL-33 et les éosinophiles, mécanisme ici révélé lorsque les mécanismes endogènes de régulation immunitaire par DPP4 sont inhibés. / Dipeptidyl peptidase-4 (DPP4 or CD26)–mediated post-translational modification of chemokines has been shown to negatively regulate lymphocyte trafficking, and its inhibition enhances T cell migration and tumor immunity by preserving functional CXCL10. In extending these initial findings to humans and pre-clinical hepatocellular carcinoma models, we discovered a new mechanism whereby DPP4 inhibition improves anti-tumor responses by eosinophil recruitment. Specifically, administration of DPP4 inhibitors (DPP4i) resulted in higher concentrations of CCL11 (or eotaxin) and increased CCR3-mediated eosinophil migration into mouse tumors. Enhanced tumor control was observed upon treatment with DPP4i, an effect strikingly preserved in Rag2–/– mice, and abrogated only upon depletion of eosinophils or inhibition of their degranulation. We further demonstrated that tumor expression of IL-33 was necessary and sufficient for eosinophil-mediated anti-tumor responses, and that this mechanism contributed to checkpoint inhibitor efficacy. These findings provide new insight into IL-33- and eosinophil-mediated tumor control, revealed when endogenous mechanisms of DPP4 immune regulation are inhibited.

O câncer cervical é uma das neoplasias mais prevalentes, sendo a segunda mais frequente em mulheres no Brasil. A exoprotease dipeptidil-peptidase IV (DPPIV), também conhecida como CD26, é uma enzima encontrada em uma diversidade de células, e sua atividade enzimática e interação com outras proteínas parecem ser fundamentais para o controle da transformação maligna e progressão tumoral. Esta enzima é encontrada ancorada na membrana celular e também como uma isoforma solúvel (DPPIV/sCD26), ativa em fluidos biológicos. Pesquisas demonstram que alterações em sua expressão e atividade têm sido observadas em diversos tumores. Tendo em vista a relação entre a DPPIV/CD26 e o câncer, neste estudo investigamos a atividade e expressão da DPPIV/CD26 em linhagens celulares de câncer cervical (SiHa, HeLa and C33A) e de queratinócitos imortalizados (HaCaT). A atividade enzimática também foi monitorada na presença do inibidor específico da DPPIV/CD26, o fosfato de sitagliptina. Avaliamos também a relação desta enzima com os mecanismos de migração e adesão celular. Nossos resultados demonstram que todas as linhagens estudadas apresentam atividade enzimática DPPIV/CD26 ligada à membrana e solúvel, sendo superior nas linhagens SiHa e HaCaT. Confirmamos que esta atividade é atribuída à DPPIV/CD26 pela inibição da sua atividade enzimática na presença de fosfato de sitagliptina. Uma maior expressão do gene da DPPIV/CD26 foi observada nas linhagens HaCaT e SiHa, uma baixa expressão na C33A, sendo praticamente indetectável na HeLa. Estes dados corroboram os resultados obtidos para a atividade enzimática. Foi observada uma maior capacidade migratória na linhagem HeLa, quando comparada a SiHa, porém na presença de fosfato de sitagliptina, a linhagem SiHa apresentou um aumento na migração. Além disso, na presença do inibidor, tanto a linhagem HeLa quanto a SiHa exibiram uma redução na adesão celular. Este estudo demonstra a presença da enzima DPPIV/CD26 em células de câncer cervical, revelando diferentes níveis de expressão, e sua relação com a migração e adesão celular. / Cervical cancer is one of the most prevalent neoplasias, being the second most frequent in women in Brazil. The exoprotease dipeptidyl peptidase IV (DPPIV), also known as CD26, is an enzyme found in a variety of cells, and its enzymatic activity and interaction with other proteins appear to be essential for the control of malignant transformation and tumor progression. This enzyme is found anchored to the cell membrane and also as a soluble isoform (DPPIV/sCD26), active in biological fluids. Studies have shown changes in their expression and activity in several tumor types. Given the relationship between DPPIV/CD26 and cancer, in the present study, we investigated DPPIV/CD26 activity and expression in cervical cancer cell lines (SiHa, HeLa and C33A) and immortalized keratinocytes (HaCaT). Enzymatic activity was also monitored in the presence of the specific DPPIV/CD26 inhibitor, sitagliptin phosphate. We also evaluated the relationship of this enzyme with cell migration and adhesion. Our results show that all cell lines studied exhibit DPPIV/CD26 enzymatic activity both membrane-bound and in soluble form, being higher in SiHa and HaCaT. We confirm that this activity is attributed to DPPIV/CD26 by its inhibition in the presence of sitagliptin phosphate. We observed a higher expression of DPPIV/CD26 in HaCaT and SiHa cell lines, a low expression in C33A and in HeLa cells this expression was almost undetectable. These data corroborate the results obtained for enzymatic activity. We observed a higher migratory capacity of HeLa, when compared to SiHa, but in the presence of sitagliptin phosphate, SiHa showed an increase in migration. Furthermore, in the presence of the inhibitor, SiHa and HeLa cells exhibited a reduction in cell adhesion. This study demonstrates the presence of DPPIV/CD26 in cervical cancer cells, revealing a differential expression and its relationship with cell migration and adhesion.